Forest Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.10.13	Pre-market Movers For Oct 22 (WHR, TRV, SYMM, NFLX, NUS, FRX, LMT, MDVN, PTIE) (RTTNews)
22.10.13	Forest Labs. Q2 Profit Soars; Revises FY14 Adj. EPS View - Quick Facts (RTTNews)
22.10.13	Earnings Watch For October 22 (UTX, TRV, JNPR, AMGN, KMB,DD) (RTTNews)
09.10.13	Pre-Market Review: Celgene Corp., Forest Laboratories Inc., Peregrine Pharma Inc., and Edwards Lifesciences Corp. (PR Newswire)
30.09.13	Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin (PR Newswire)
17.09.13	Trevena Names Roberto Cuca SVP, CFO - Quick Facts (RTTNews)
17.09.13	Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer (PR Newswire)
17.09.13	Clinical Trial Updates, Appointments, FDA Acknowledgments and Qualifications - Research Report on Novartis, Endo, The Medicines Company, United Therapeutics, and Forest (PR Newswire)
13.09.13	Forest Labs' Ceftazidime/avibactam Combination Gets QIDP Designation From FDA (RTTNews)
10.09.13	Forest Laboratories Names Director Brent Saunders As President, CEO (RTTNews)
10.09.13	Forest Labs. Names Brenton Saunders CEO And President - Quick Facts (RTTNews)
06.09.13	Early Briefing and Review: Celgene Corp., Edwards Lifesciences Corp., Forest Laboratories Inc., and Peregrine Pharma Inc. (PR Newswire)
02.09.13	Acquisitions, NDA Filings, Key Findings, Conferences and Product Launches - Research Report on Perrigo, Forest Labs, Avanir Pharmaceuticals, Cubist Pharmaceuticals, and Dr. Reddy's Laboratories (PR Newswire)
15.08.13	SPRING Makes AMPE Jump, AVNR Buys Peace, FRX Delays NDA Submission (RTTNews)
14.08.13	Forest Labs, Almirall Delay NDA Filing For Aclidinium/formoterol Combination (RTTNews)
31.07.13	Morning Research: Celgene, Edwards Lifesciences, Forest Laboratories, and Peregrine Pharma (PR Newswire)
30.07.13	Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study (PR Newswire)
29.07.13	Seeking Growth Opportunities through Understanding Market Trends, Strengthened R&D, and Global Expansion - Research Report on WellPoint, Thermo Fisher, Varian, Medicines Co., and Forest Laboratories (PR Newswire)
23.07.13	Forest Labs. Q1 Profit Falls, Adj. EPS Flat - Quick Facts (RTTNews)
23.07.13	Earnings Watch For July 23 (DD, AAPL, T, EA, JNPR, UPS, VMW) (RTTNews)
22.07.13	Forest Labs Announces Additional Settlement Agreement In BYSTOLIC Patent Dispute (RTTNews)
12.09.09	Forest Laboratories Presents Analysis of Two Positive Pivotal Phase III Studies of Ceftaroline for the Treatment of Community-Acquired Pneumonia (CAP) at ICAAC (Businesswire)
21.07.09	Forest Laboratories, Inc. Reports Fiscal First Quarter 2010 Earnings Per Share of $0.87 (Businesswire)
04.03.08	Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies (PR Newswire)
31.12.07	Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome (PR Newswire)
18.12.07	Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension (PR Newswire)
01.11.07	Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension (PR Newswire)
03.07.07	Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 First Quarter Earnings (PR Newswire)
06.12.06	Lexapro(R) Demonstrated Significance on Prospectively Defined Efficacy Parameter and Was Better Tolerated Than Cymbalta(R) in Treatment of Depression (PR Newswire)
23.10.06	U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem (PR Newswire)
25.04.06	Seven Summits Research Releases Comments on OXY, FRX, WHR, COH, and BNI (PR Newswire)
10.04.06	Forest and Almirall Announce a Development and Marketing Collaboration Agreement on New Therapy for COPD (PR Newswire)
18.10.05	Forest Laboratories Reports Earnings Per Share of $0.59 for Q2'06 (PR Newswire)
20.07.05	MORNING UPDATE: Mankus-Lavelle Group issues alerts for MOT, JNPR, MO, MEL, and FRX (PR Newswire)
14.07.05	Forest Laboratories, Inc. to Continue Clinical Development of Neramexane Based on New Clinical Trial Results (PR Newswire)
21.03.05	MORNING UPDATE: Man Securities Inc. issues alerts for AIG, DRL, ADBE, (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	545.60	2.17 %	K V
Sika	235.80	1.51 %	K V
CieFinRichemont	127.65	1.43 %	K V
Part Grp Hldg	1’299.50	1.33 %	K V
Holcim	91.86	1.15 %	K V
Roche Hldg G	254.50	-0.66 %	K V
Lonza Grp	525.00	-0.72 %	K V
Sonova Hldg	297.70	-1.03 %	K V
Alcon	77.12	-1.20 %	K V
Swiss Life Hldg	690.40	-4.69 %	K V

mehr

17:58		STOXX-Handel: STOXX 50 zum Handelsende im Aufwind
17:58		FTSE 100 aktuell: FTSE 100 verbucht schlussendlich Zuschläge
16:02		S&P 500-Titel Pfizer-Aktie: So viel hätte eine Investition in Pfizer von vor 3 Jahren gekostet
15:58		Gute Stimmung in Europa: STOXX 50 am Dienstagnachmittag im Plus
15:58		Aufschläge in London: FTSE 100 am Dienstagnachmittag in Grün
12:26		Pluszeichen in London: FTSE 100 im Aufwind
09:28		FTSE 100 aktuell: Zum Start Pluszeichen im FTSE 100
02.12.24		Handel in Europa: STOXX 50 verbucht schlussendlich Zuschläge

17:58

STOXX-Handel: STOXX 50 zum Handelsende im Aufwind

17:58

FTSE 100 aktuell: FTSE 100 verbucht schlussendlich Zuschläge

16:02

S&P 500-Titel Pfizer-Aktie: So viel hätte eine Investition in Pfizer von vor 3 Jahren gekostet

15:58

Gute Stimmung in Europa: STOXX 50 am Dienstagnachmittag im Plus

15:58

Aufschläge in London: FTSE 100 am Dienstagnachmittag in Grün

12:26

Pluszeichen in London: FTSE 100 im Aufwind